Professor Dr. Mahmoud Alhosin obtained his PhD from the Faculty of Pharmacy at the University of Strasbourg (France). A specialist in cancer epigenetics, his research has contributed to a deeper understanding of regulatory mechanisms involving key proteins such as UHRF1, DNMT1, and HDAC1. His work has notably focused on the interactions between natural compounds, epigenetic mechanisms, and cellular regulatory pathways, opening new perspectives in the identification and scientific valorization of natural bioactives of interest. Building on this scientific expertise, EPIGSOIN develops innovative natural solutions inspired by the latest advances in modern research, with a particular focus on the valorization of bioactives derived from Nigella sativa. Our objective is to transform scientific discoveries into high-quality formulations developed according to elevated standards of naturality, safety, innovation, and scientific excellence.